Status:
COMPLETED
Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis
Lead Sponsor:
Ciudad Universitaria, Spain
Conditions:
Osteoporosis
Eligibility:
FEMALE
Phase:
NA
Brief Summary
The purpose of this study is to determine the duration of the treatment with alendronate in postmenopausal women with osteoporosis.
Detailed Description
The duration of the treatment with alendronate is not well established. The investigators recruited 228 women with postmenopausal osteoporosis. They all received alendronate during the first 3 years o...
Eligibility Criteria
Inclusion
- postmenopausal osteoporosis under densitometric criteria of the World Health Organization
Exclusion
- secondary osteoporosis
- alteration in analytic parameters (total proteins, calcium, phosphorus, vitamin D, parathyroid hormone, thyroid hormone, transaminase, creatinine)
Key Trial Info
Start Date :
January 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2004
Estimated Enrollment :
228 Patients enrolled
Trial Details
Trial ID
NCT00936260
Start Date
January 1 1998
End Date
December 1 2004
Last Update
July 10 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University San Carlos Hospital
Madrid, Madrid, Spain, 28040